Journal of Stem Cells and Regenerative Medicine
 
 
   

News Letter - 32                       vol.2; iss.15                              11 Aug 2011

 
   

CURRENT STEM CELL NEWS

1. Studies exploring the potentials of Stem Cell Therapy for Kidney Disease

Two recent studies by separate teams, one on reprogramming extracted kidney cells to behave like other kidney cells and second on reprogramming kidney cells from urine have created hope for patients suffering from kidney diseases. Click to read more...

2. New strategies to help donor adult stem cell transplants overcome immune rejection

Researchers using a new strategy have shown for the first time that it is possible to regulate adult blood stem cells to overcome an immune response that leads to transplant rejection.Click to read more...

3. Sperms made in lab from stem cells

Researchers have successfully coaxed mouse embryonic stem cells into sperm precursors, and shown that these cells can give rise to healthy sperms in the laboratory. Click to read more...

4. Less known roles of erythropoietin revealed

It has been identified that low doses of erythropoietin (EPO), a hormone, might reduce the risk of heart failure associated with a few anticancer therapies.Click to read more...

5. Brain grows at expense of other organs during growth restriction before birth

By studies in drosophila, scientists have uncovered new molecular mechanisms behind the phenomenon by which the growing brain is protected at the expense of other less critical organs during growth restriction in the womb.Click to read more...

6. Brain cells generated from Skin cells

In a recent study researchers have reported efficient and robust methods for transforming adult skin cells into functioning brain cells and this study will have potential applications in neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's disease in the future.Click to read more...

7. Mutations in mitochondrial genome during iPS reprogramming

As a setback to iPS research, Max Planck Institute’s Researchers have identified that the genome of the mitochondria is particularly vulnerable to mutations during reprogramming of iPS cells. Click to read more...

8. Signalling affects neural stem cell fate

A signalling pathway which plays a key role in development, has also been found to be an active regulator of neural stem cell fate based on the location of the cells in the adult brain.Click to read more...

9. Global Clinical trial on Stem cells for treating Multiple sclerosis

A £10 million trial, involving up to 200 patients around the world on stem cell therapy for multiple sclerosis is due to start later this year.Click to read more...

10. Sugar and Metabolism- Implications in stem Cell fate

Researchers at Mayo Clinic have demonstrated the mechanism by which cellular metabolism can alter stem cell fate.Click to read more...

Really???

1. It is a fact that each of us shed nearly 40lbs of skin in our life time

  2. Did you know that the Ebola virus kills 4 out of every 5 humans it infects and it is a Biosafety level 4 agent, as well as a Category A bioterrorism agent

 
 

Events

 

1. World Stem Cell Summit;
October 3-5, 2011, Pasadena,CA. For details Click here

2. NCRM N I C H E 2011- Sixth Anniversary of Nichi-In Centre for Regenerative Medicine
Fujio Cup Quiz 2011, Plenary Session and Symposium on "Stem Cell and Regenerative Medicine",
15th October 2011, Chennai, India. For details click here

3.2nd International Conference on Stem Cells and Cancer (ICSCC-2011)
Oct 15 -19 - Pune, India.  For details Click here

4. 2nd meeting of ACTO (Asian Cell Therapy Organization)
October 17-20, Miyazaki Prefecture, Japan. For details Click here

 
 

Quote Corner:

“In rivers, the water that you touch is the last of what has passed and the first of that which comes; so with present time. ”

- - Leonardo da Vinci

 

This bulletin is sponsored by

 
 
 

To submit your article
in JSRM click here

To advertise in this weekly
JSRM News Letter, send a
request mail to

webmaster@pubstemcell.com

   
 
Copyright © Journal of Stem Cells & Regenerative Medicine. All rights reserved.
Disclaimer